Stockreport

Immunovant drops 7%, prices $550M stock offering [Seeking Alpha]

Roivant Sciences Ltd.  (ROIV) 
PDF Roivant Sciences, the company's controlling stockholder, has agreed to purchase shares in the offering. All of the shares are to be sold Recommended For You More Tr [Read more]